Experts Elevate New Drugs for Diabetic Kidney Disease Uncategorized / June 16, 2022 A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow progression of diabetic kidney disease. Medscape Medical News